
New Norwegian collaboration in radiopharmacy against cancer
Thor Medical has entered an agreement with Node Pharma to supply isotopes.

Thor Medical has entered an agreement with Node Pharma to supply isotopes.

A new governmental plan makes bold promises to attract clinical studies to Norway, but will it deliver?

The government wants to focus Siva's activities solely on real estate. This is presented as a technical reorganisation, but in reality it is a political choice about the role the state should play in the development of new industries. We cannot spend innovation capital and expect to become richer.

Fire videregående-elever fra Ullern tilbrakte to dager på patologiavdelingen på Radiumhospitalet. Det skulle vise seg å bli noe av det mest spennende de hadde gjort, og ga dem bekreftelse på videre utdanningsløp.

Oslo Cancer Cluster Incubator based team was awarded NOK 3 450 000 from a record allocation of NOK 45.6 million in research funding announced by the Norwegian Childhood Cancer Society.

Cancer Crosslinks turns 18 years in 2026, making it one of the best-established cancer meeting series in Norway. This is what it looks like.
Get monthly news updates and invitations to events from our oncology cluster.

Kronikk. USA peker, kanskje ufrivillig, på noe viktig: Fremtidens legemiddelutvikling krever at flere bidrar, på flere måter enn bare gjennom pris.

We are pleased to introduce the newest members of our cluster, Barnekreftforeningen and BearingPoint.

Get to know the leading scientists and clinicians taking the stage at the new edition of Cancer Crosslinks.

Oslo Cancer Cluster, in collaboration with the Berlin Center for Gene and Cell Therapies, has published a new whitepaper titled “Bridging the Gaps: Unlocking the Future of Advanced Therapies in Europe via Novel Alliances.”

Stakeholders from across the Norwegian and European health innovation ecosystem gathered for the Oslo Deep Dive Days.

Photocure won the Norwegian Cancer Society Innovation Prize during the 10th anniversary celebration of Oslo Cancer Cluster Innovation Park.

